FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series A / Health care startups that raised Series A in Switzerland

Health care startups that raised Series A in Switzerland

Updated 16 Nov 2026

Reset
Health care startups that raised Series A in Switzerland
One-time CSV
  • 89 funded companies, 59 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-a~switzerland.csv89 rows × 18 columns
CompanyCityLast roundAmountDate
RiviaZürichSeries A$15.0M2026-03-18
Leman BiotechLausanneSeries A$28.8M2026-01-26
ComphyaLausanneSeries A$4.0M2025-07-08
OdneDubendorfSeries A$5.2M2025-06-12
RhygazeBaselSeries A$86.0M2025-01-10
LyfegenBaselSeries A$5.7M2024-12-11
VandriaLausanneSeries A$10.1M2024-08-21
NeurosterixGenevaSeries A$65.0M2024-04-03

8 rows of the CSV in 5 of its 18 columns.

89
Startups
$1.0B
Total raised
5
Funded in the last 12 months
$60.8M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

28 of 89
28 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Rivia Rivia provides an operating system that aims to improve clinical trial outcomes. Artificial intelligence Zürich Series A $15.0M 2026-03-18 $18.2M Speedinvest, Nina Capital, Amino Collective 1 to 10 2022
Leman Biotech Leman Biotech develops cancer immunotherapies as a biotech company. Biotech Lausanne Series A $28.8M 2026-01-26 $46.8M Tiantu Capital, Fuho Capital 11 to 50 2021
Comphya Comphya develops an active implantable medical device to restore erectile function in patients who do not respond to oral drugs. Biotech Lausanne Series A $4.0M 2025-07-08 $14.2M Venture Kick, Verve Ventures, Nest Collective Foundation 1 to 10 2017
Rhygaze Rhygaze develops a gene therapy that targets cone cells to restore vision in blinding diseases. Biotech Basel Series A $86.0M 2025-01-10 $97.3M Google Ventures, F-Prime, ARCH Venture Partners +2 11 to 50 2024
Lyfegen Lyfegen provides SaaS rebate management software for the healthcare industry. Fintech Basel Series A $5.7M 2024-12-11 MassChallenge, Innosuisse, APEX Ventures +1 51 to 100 2018
Vandria Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders. Health care Lausanne Series A $10.1M 2024-08-21 Innosuisse, Dolby Family Ventures, Eurostars +1 1 to 10 2021
Neurosterix Neurosterix is a biopharmaceutical firm creating allosteric modulators for neurological illnesses. Biotech Geneva Series A $65.0M 2024-04-03 $65.0M Perceptive Advisors, Xontogeny, Acorn Bioventures 11 to 50 2024
Spirecut Spirecut makes ultrasound-guided instruments that make minimally invasive surgery widely accessible. Health care Muttenz Series A $800K 2024-03-26 $2.2M Innovate UK, MassChallenge Switzerland, Innosuisse +1 1 to 10 2020
Scailyte Scailyte delivers precision medicine through single-cell science. Artificial intelligence Basel Series A $1.8M 2023-12-04 $15.6M Venture Kick, Verve Ventures, Innosuisse +2 11 to 50 2017
mybacs mybacs is a research-driven direct-to-consumer company specializing in the human microbiome. Commerce Zug Series A $5.9M 2023-10-19 Global Founders Capital, Social Starts, Joyance Partners +2 51 to 100 2019
TOLREMO therapeutics TOLREMO therapeutics develops small molecules that target drug resistance pathways in cancer therapy. Biotech Zürich Series A $37.9M 2023-09-20 Altos Ventures, redalpine, BioMedPartners +1 11 to 50 2017
NewBiologix NewBiologix is a technology innovation company. Biotech Epalinges Series A $50.3M 2023-05-11 $50.3M Recipharm Venture Fund 11 to 50 2023
PeakData PeakData provides a software platform that identifies and analyzes key opinion leaders in a therapeutic area. Artificial intelligence Zug Series A $12.4M 2022-08-22 Octopus Ventures, AlbionVC, Heal Capital 51 to 100 2017
CDR-Life AG CDR-Life AG develops therapeutic antibody fragments for immuno-oncology. Biotech Schlieren Series A $76.0M 2022-04-13 $76.0M RA Capital Management, Omega Funds, Jeito Capital 51 to 100 2017
Cimeio Therapeutics Cimeio Therapeutics develops curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders. Biotech Basel Series A $50.0M 2022-04-13 $50.0M Versant Ventures 11 to 50 2020
Embion Technologies Embion Technologies offers industrial biomass processing technology for nutrition, pharma, and cosmetics applications. Biotech Lausanne Series A $4.9M 2021-12-08 Venture Kick, Foundation for Innovation and Technology (FIT), Swiss Economic Award 1 to 10 2016
Anjarium Biosciences Anjarium Biosciences develops non-viral gene therapies to treat genetic diseases. Biotech Schlieren Series A $60.4M 2021-09-15 Gimv, Omega Funds, Pfizer Venture Investments +2 1 to 10 2017
Chord Therapeutics Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases. Biotech Geneva Series A $16.0M 2020-10-13 Omega Funds, Eclosion SA 1 to 10 2014
POLYNEURON Polyneuron is a pharmaceutical company developing a new drug class for autoimmune disorders. Biotech Basel Series A $15.4M 2020-09-16 $45.0M New Enterprise Associates, Venture Kick, Sofinnova Partners +1 1 to 10 2014
yamo Yamo sells food products for children directly to consumers. Commerce Zug Series A $11.4M 2020-07-09 b2venture, BackBone Ventures, Polytech Ventures +2 51 to 100 2016
Saphetor Saphetor is a company that develops personalised medicine. Biotech Lausanne Series A $4.2M 2020-03-27 $6.6M Foundation for Innovation and Technology (FIT), GoBeyond, Alpana Ventures +1 51 to 100 2014
Inthera Bioscience Inthera Bioscience develops inhibitors of intracellular protein interactions using a proprietary technology platform. Biotech Schlieren Series A $5.5M 2018-06-26 Microsoft Accelerator, Novo Holdings, M Ventures +2 11 to 50 2013
Intelligent Sensory concept Intelligent Sensory concept is a biotechnology company that specializes in photomodulation. Biotech Geneva Series A $2.0M 2018-05-18 Rhône Finance 11 to 50 2015
PIQUR Therapeutics PIQUR Therapeutics is a Swiss pharmaceutical company developing anti-cancer drugs. Biotech Basel Series A $30.9M 2017-09-01 $86.9M Venture Kick, Versant Ventures 11 to 50 2011
Pevion Biotech Pevion Biotech is a biotechnology company that uses its proprietary technology platforms. Biotech Bern Series A $29.2M 2007-08-13 $29.2M BB Biotech Ventures, BZ Bank 11 to 50 2002
4-Antibody AG 4-Antibody AG develops a human antibody drug-discovery platform for immuno-oncology therapeutics. Biotech Basel Series A $18.4M 2007-01-16 $20.6M EQT Life Sciences, BioMedPartners, Grazia Equity +2 251 to 500 2002
Moda Technology Partners Moda Technology Partners develops commercial software. Health care Basel Series A $2.3M 2006-07-11 Osage Venture Partners 11 to 50 2005
Roche Glycart Roche Glycart researches, develops, and commercializes antibody-based biotechnology products. Biotech Schlieren Series A $13.6M 2003-11-26 $13.6M Forbion Capital Partners, Novartis Venture Fund, BioMedPartners +1 101 to 250 2000

Table 1. Health care startups that raised Series A in Switzerland: the 28 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 89.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Leman Biotech Leman Biotech develops cancer immunotherapies as a biotech company. Biotech Lausanne Series A $28.8M 2026-01-26 $46.8M Tiantu Capital, Fuho Capital 11 to 50 2021
2 Rivia Rivia provides an operating system that aims to improve clinical trial outcomes. Artificial intelligence Zürich Series A $15.0M 2026-03-18 $18.2M Speedinvest, Nina Capital, Amino Collective 1 to 10 2022

Table 2. Health care startups that raised Series A in Switzerland: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Venture Kick Startup incubator Schlieren, Switzerland 12 13%
2 Foundation for Innovation and Technology (FIT) Entrepreneurship program Lausanne, Switzerland 5 6%
3 Innosuisse Government investment office Berne, Switzerland 4 4%
4 Verve Ventures Venture capital firm Zug, Switzerland 3 3%
5 Novartis Venture Fund Corporate venture arm Basel, Switzerland 3 3%
6 BioMedPartners Venture capital firm Basel, Switzerland 3 3%
7 Omega Funds Secondary purchaser Boston, United States 3 3%
8 b2venture Venture capital firm Berlin, Germany 2 2%
9 Versant Ventures Venture capital firm Menlo Park, United States 2 2%
10 M Ventures Corporate venture arm Amsterdam, The Netherlands 2 2%
11 Gilde Healthcare Private equity firm Utrecht, The Netherlands 2 2%
12 Polytech Ventures Micro VC fund Lausanne, Switzerland 2 2%
13 Amino Collective Venture capital firm Berlin, Germany 1 1% 1 Rivia
14 Nina Capital Micro VC fund Barcelona, Spain 1 1% 1 Rivia
15 Speedinvest Venture capital firm Vienna, Austria 1 1% 1 Rivia

Table 3. Health care startups that raised Series A in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 47 53% $744.4M
Software 20 22% $109.4M
Artificial intelligence 11 12% $67.6M
Hardware 4 4% $44.8M
Commerce 4 4%
Fintech 1 1%
Energy 1 1%

Table 4. Health care startups that raised Series A in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 89 100% $5.9M

Table 5. Health care startups that raised Series A in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Basel 14 16%
Zürich 13 15%
Lausanne 13 15%
Epalinges 6 7%
Schlieren 6 7%
Geneva 4 4%
Zug 4 4%
Neuchâtel 3 3%
Pfaffikon 2 2%
Risch 1 1%
Wallisellen 1 1%
Dubendorf 1 1%

Table 6. Health care startups that raised Series A in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 20% $4.8M
June 2026 1 20% $5.3M
March 2026 2 40% $22.0M
January 2026 1 20% $28.8M

Table 7. Health care startups that raised Series A in Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 5 6% $60.8M
2025 9 10% $178.8M
2024 13 15% $159.0M
2023 8 9% $133.9M
2022 5 6% $181.4M
2021 13 15% $114.3M

Table 8. Health care startups that raised Series A in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 3 3%
2020 to 2022 13 15%
2015 to 2019 39 44%
2010 to 2014 22 25%
Before 2010 12 13%

Table 9. Health care startups that raised Series A in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 27 31%
11 to 50 44 50%
51 to 100 13 15%
101 to 250 3 3%
251 to 500 1 1%

Table 10. Health care startups that raised Series A in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Switzerland whose last round is Series A are on the list?
89, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 89 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series A in Switzerland: 89 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Switzerland

Other sectors that raised Series A in Switzerland

Cite: FundingWatcher, 89 health care companies in Switzerland whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-a/switzerland/